Carolin_Mogler.jpg

PD Dr. Carolin Mogler

Project Z2

Institute of Pathology Technical University, Munich

​

​

​

​

carolin.mogler(at)tum.de

Carolin Mogler attended Medical School at Heidelberg University. She obtained her MD from Heidelberg University where she investigated heperanase expression on head and neck cancers before she moved on to the Institute of Pathology (Director: Peter Schirmacher) where she got her board certification in surgical pathology 2013. Since 2015 she is consultant pathologist at the Institute of Pathology at the Technical University in Munich, since 2018 managing senior consultant.

Qualifications and Scientific Curriculum

200-2007

2009

2007-2015

2013

2007-2015

since 2015

Medical School, Heidelberg University, Germany

​

MD: Institute of Pathology, Heidelberg University, Germany

​

Institute of Pathology, Heidelberg University, Germany

​

Board certification surgical pathology

​

Institute of Pathology, Heidelberg University

​

Consultant surgical pathologist, Institute of Pathology, Technical University Munich, Germany

​

Managing senior consultant, , Institute of Pathology, Technical University Munich, Germany

since 2018

Selected publications

​

  1. Abdul Pari AA, Singhal M, Hübers C, Mogler C, Schieb B, Gampp A, Gengenbacher N, Reynolds LE, Terhardt D, Géraud C, Utikal J, Thomas M, Goerdt S, Hodivala-Dilke KM, Augustin HG, Felcht M. Tumor Cell-Derived Angiopoietin-2 Promotes Metastasis in Melanoma. Cancer Res,  80:2586-2598, 2020.

  2. Steiger K, Ballke S, Yen HY, Seelbach O, Alkhamas A, Boxberg M, Schwamborn K, Knolle PA, Weichert W, Mogler C. Histopathologische Forschungslabors in der translationalen Forschung : Konzeption sowie Integration in die Infrastruktur pathologischer Institute [Histopathological research laboratories in translational research: Conception and integration into the infrastructure of pathological institutes]. Pathologe. 2019 Mar;40(2):172-178. German.

  3. Mogler C, Koschny R, Heilig CE, Frohling S, Schirmacher P, Weichert W, Pfarr N: Molecular characterization of hepatic epithelioid hemangioendothelioma reveals alterations in various genes involved in DNA repair, epigenetic regulation, signaling pathways, and cell cycle control. Genes Chromosomes Cancer. 2020 Feb;59(2):106-110.

  4. Mogler C, König C, Wieland M, Runge A, Besemfelder E, Komljenovic D, Longerich T, Schirmacher P, Augustin HG: Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin. EMBO Mol Med, 9:741-9, 2017.

  5. Mogler C, Boxberg M, Knebel C, Weichert W, Wörtler K, Specht K: Spindelzellige osteosklerotische Knochenläsion mit MDM2-Amplifikation [Spindle-cell osteosclerotic bone lesion with MDM2 amplification]. Pathologe. 2018 Mar;39(2):186-190. German.

  6. Wieland E, Rodriguez-Vita J, Liebler SS, Mogler C, Moll I, Herberich SE, Espinet E, Herpel E, Menuchin A, Chang-Claude J, Hoffmeister M, Gebhardt C, Brenner H, Trumpp A, Siebel CW, Hecker M, Utikal J, Sprinzak D, Fischer A: Endothelial Notch1 Activity Facilitates Metastasis. Cancer Cell 31:355-67, 2017.

  7. Viski C, König C, Kijewska M, Mogler C, Isacke CM, Augustin HG: Endosialin-expressing pericytes promote metastatic dissemination. Cancer Res, 76:5313-25, 2016.

  8. Scholz B, Korn C, Wojtarowicz J, Mogler C, Augustin I, Boutros M, Niehrs C, Augustin HG: Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling. Dev Cell, 36:79-93, 2016.

  9. Mogler C, Wieland M, König C, Hu J, Runge A, Korn C, Besemfelder E, Breitkopf-Heinlein K, Komljenovic D, Dooley S, Schirmacher P, Longerich T, Augustin HG: Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. EMBO Mol Med, 7:332-8, 2015.

  10. Hu J, Srivastava K, Wieland M, Runge A, Mogler C, Besemfelder E, Terhardt D, Vogel MJ, Cao L, Korn C, Bartels S, Thomas M, Augustin HG: Endothelial cell-derived Angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science, 343:416-9, 2014.